ストレプトマイシン使用患者の眩暈に対するトラベルミン応用経験

　1948年Waksman及び其の協同研究者に依るストレプトマイシン（以下Stと省す）発見以来，肺結核及び其の他の結核症に対する本剤の効果は，すでに多数の人々の認める所であるが，其の副作用として，特に聴器に対する親和性も又周知の事実である。

　私達は国立筑紫病院に於いて，St注射を受けた肺結核患者の中，耳性眩暈を訴える患者にトラベルミン（以下Tと省す）を使用する機会を得たので，こゝに報告し，先賢の御批判を仰ぎたいと思う。

NISHIKAWA and Suyeyoshi test use of Travelmin in the treatment of vertigo which is induced as a complication during or follo-wing streptomycin therapy. The symptom manifestations of vertigo may be divided into types that might be either, acute or chronic. To the acute type Travelmin is effective by establishing a complete cure or alleviation of symptom to a large measure; to the chronic its actions may be no more than establishing temporary relief. Other side effects caused by streptomycin therapy such as tinnitus au-rium, chills and nausea are effectively relieved by this agent. However, the latter has in itself certain side effects of its own by pro-ducing feelings of slight malaise and drowsi-ness which generally, disappear in 1 or 2 days after discontinuation of the drug.